Mayor Booker Cuts Ribbon to Open CGC Genetics, Inc		Prize Ernst & Young Emerging Entrepreneur of the Year		CGH - Comparative Genomic Hybridization		CGC Genetics Professor Doutor Amândio Tavares Award, 4th Edition
“This is an example of the powerful results of people coming together,” stated Mayor Booker. “I welcome CGC Genetics, Inc. to the City of Newark and commend all of the partners that facilitated the opening of their United States headquarters here in our City. This kind of unity gives me the sense that we can achieve all that we dream.”		The Jury of the Prize Ernst & Young Entrepreneur of the Year, chaired by Dr. Basilio Horta, awarded the distinction of "Emerging Entrepreneur" to Purificação Tavares, CEO and Clinical Director of the CGC Genetics.		Traditionally, diagnosis of genetic causes of mental retardation (also referred to as developmental delay) has depended upon cytogenetic and/or FISH analysis of deletion syndromes. Recent technological advances have demonstrated the existence of many additional genetic variations/micro-deletion syndromes that cannot be detected by cytogenetics. A microarray-based system known as comparative genomic hybridization (CGH)...		CGC Genetics Award ‘Professor Doutor Amândio Tavares’, created in June 2006 to reward innovation works in the field of Medical Genetics, was delivered July 5th, during the 18th Conference SinASE.

ARRAY CGC for Craniosynostosis		ARRAY CGC - Molecular Diagnosis of Noonan Syndrome and other Genetically Related Syndromes		Psychomotor Development Delay		ARRAY CGC for Skeletal Dysplasia
This is a brief description of the advantages of complementing clinical diagnosis (including prenatal diagnosis), in all cases where there is an evidence of Craniosynostosis, by performing the molecular testing for the most frequent syndromes presenting this symptom, using a new microarray technology...		The ARRAY CGC was developed to complement the clinical diagnosis in all cases where there is a suspicion of Noonan Syndrome. This technology identifies in a single test, the most frequent gene mutations associated with Noonan Syndrome as well as other genetically related syndromes. This panel is also designed for Prenatal diagnosis. The following text was produced by the CGC Genetics R&D Team.		The psychomotor development delay is one of the clinically situations in which is difficult to find the etiopathogenesis. GCC Genetics has developed a new strategy based on a sequential approach, with results in one to two weeks for each step...		This is a brief description of the advantages of complementing prenatal clinical diagnosis, where there is no conclusive diagnosis of a specific foetal skeletal dysplasia, by performing the molecular diagnosis for the more frequent skeletal diseases, using a new microarray technology...

ARRAY CGC for Trombophilia and Warfarin Pharmacogenetics		PND plus+		Array CGC - Molecular Diagnosis of congenital deafness		CGC is licensed in the State of California
This is a brief description of the molecular screening test for hereditary thrombophilia and warfarin pharmacogenetics, using a new MicroArray technology.		Prenatal Diagnosis plus+, developed by the CGC Genetics R&D team, offers a panel of options, using several methods, including microarrays, that could complement or complete the conventional prenatal diagnosis. The set of disorders included were defined according to the potential for disease prevention, early treatment / intervention and health care improvement...		This is a description of the advantages of using new Microarray technology to complement clinical diagnosis in all cases where there is an evidence of congenital hearing loss. This technology identifies in a single test, the most frequent gene mutations associated with this clinical diagnosis. The following text was produced by the CGC Genetics R&D Team.		CGC's license for the State of California was approved last January by California Department of Public Health (CDPH)...

GENETIC TESTS at CGC Centro de Genética Clínica		Arrays CGC (Patent Pending)		CGC in Health Cluster Portugal		CGC Centro de Genética Clínica in COTEC Innovative SMEs Network
Genetic tests are nowadays presented as tests of easy access, for clinical and non-clinical applications, frequently raising questions about its real utility and medical application. Therefore, CGC intends to provide the following clarifications to all interested in our services...		The new microarray tests offered by CGC genetics provide a method of achieving a fast, cost-effective diagnosis of diseases with genetic background, using a unique approach. This breakthrough utilizes clinical features of the disease and its differential diagnosis, to define logical panels to study arranged by groups of signs or symptoms of the diseases.		CGC Centro de Genética Clínica (CGC), the first private medical genetics laboratory in Portugal, is one of the sixty-eight institutions that constitute the competitiveness and technology pole - Health Cluster Portugal (HCP). The main objective of HCP is...		CGC Centro de Genética Clínica belongs since 2007 to COTEC Innovative SMEs Network. The aim of this initiative is...